Lv12
45 积分 2023-04-24 加入
Use of SGLT2i in Non-Diabetic Kidney Transplant Recipients
1天前
已完结
Impact of Empagliflozin on Cardiac Arrhythmias and Heart Rate Variability in Kidney Transplant Recipients
1天前
已完结
Comparison of Clinical Outcomes Between Two Types of Dipeptidyl Peptidase-4 Inhibitors in Posttransplant Diabetes Mellitus in Kidney Transplantation Recipients: A Nationwide Population-Based Cohort Study in Korea
1天前
已完结
The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers
1天前
已完结
Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients
1天前
已完结
Sodium-glucose co-transporter 2 inhibitors & glucagon-like peptide-1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients
1天前
已完结
Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD
11天前
已完结
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
1个月前
已完结
The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes
1个月前
已完结
皖公网安备34019202002308
